Cell Viability Assays Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066472
  • May 2021
  • Medical Devices
  • 131 Pages
The global Cell Viability Assays market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Cell Viability Assays market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Cell Viability Assays market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Cell Viability Assays market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, Becton, Dickinson and Company, Promega Corporation, Abcam PLC, Perkinelmer, Biotek Instruments
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Cell Viability Assays market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Cell Viability Assays market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Cell Viability Assays market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Cell Viability Assays market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Cell Viability Assays Market:
The Cell Viability Assays market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, Becton, Dickinson and Company, Promega Corporation, Abcam PLC, Perkinelmer, Biotek Instruments

Cell Viability Assays Market Segment Analysis:
By Product
Consumables
Instruments
Cell Type
Human Cells
Animal Cells
Microbial Cells
Application
Drug Discovery and Development
Basic Research
Stem Cell Research
Clinical and Diagnostic Applications
Other Applications
End User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospital and Diagnostic Laboratories
Other End Users

Geographic Coverage for Cell Viability Assays Market:
The market research report on global Cell Viability Assays market offers complete analysis across various regions across the world. The Cell Viability Assays market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Cell Viability Assays market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Cell Viability Assays Market Value and Forecast
  • US
  • Canada
Europe Cell Viability Assays Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Cell Viability Assays Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Cell Viability Assays Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Cell Viability Assays Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Cell Viability Assays market report:
  • The report provides key trends of the global Cell Viability Assays market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Cell Viability Assays industry
  • The report covers all the recent developments of the Cell Viability Assays market and helps to provide current industry updates
  • The report covers a detailed look over the global Cell Viability Assays Industry and provides with significant actionable insights
  • The Cell Viability Assays market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Cell Viability Assays market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Cell Viability Assays market
  • Comprehensive analysis of the Cell Viability Assays market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Cell Viability Assays market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Cell Viability Assays market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Cell Viability Assays market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Cell Viability Assays market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Cell Viability Assays market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • GE Healthcare
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Promega Corporation
  • Abcam PLC
  • Perkinelmer
  • Biotek Instruments
  • Consumables
  • Instruments
  • End UserEnd Users

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Cell Viability Assays Market Snapshot
          2.1.1. Global Cell Viability Assays Market By Product,2019
               2.1.1.1.Consumables
               2.1.1.2.Instruments
          2.1.2. Global Cell Viability Assays Market By End UserEnd Users,2019
               2.1.2.1.End UserEnd Users
          2.1.3. Global Cell Viability Assays Market By End-use,2019
          2.1.4. Global Cell Viability Assays Market By Geography,2019

3. Global Cell Viability Assays Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Cell Viability Assays Market Size (US$), By Product, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product, 2020
     4.2. Global Cell Viability Assays Market Size (US$), By Product, 2018 – 2028

5. Global Cell Viability Assays Market Size (US$), By End UserEnd Users, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End UserEnd Users, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End UserEnd Users, 2020
     5.2. Global Cell Viability Assays Market Size (US$), By End UserEnd Users, 2018 – 2028

6. Global Cell Viability Assays Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Cell Viability Assays Market Size (US$), By End-use, 2018 – 2028

7. Global Cell Viability Assays Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Cell Viability Assays Market Analysis, 2018 – 2028 
          7.2.1. North America Cell Viability Assays Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Cell Viability Assays Market Size (US$), By Product, 2018 – 2028
          7.2.3. North America Cell Viability Assays Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.2.4. North America Cell Viability Assays Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Cell Viability Assays Market Analysis, 2018 – 2028 
          7.3.1.  Europe Cell Viability Assays Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Cell Viability Assays Market Size (US$), By Product, 2018 – 2028
          7.3.3. Europe Cell Viability Assays Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.3.4. Europe Cell Viability Assays Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Cell Viability Assays Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Cell Viability Assays Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Cell Viability Assays Market Size (US$), By Product, 2018 – 2028
          7.4.3. Asia Pacific Cell Viability Assays Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.4.4. Asia Pacific Cell Viability Assays Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Cell Viability Assays Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Cell Viability Assays Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Cell Viability Assays Market Size (US$), By Product, 2018 – 2028
          7.5.3. Latin America Cell Viability Assays Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.5.4. Latin America Cell Viability Assays Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Cell Viability Assays Market Analysis, 2018 – 2028 
          7.6.1.  MEA Cell Viability Assays Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Cell Viability Assays Market Size (US$), By Product, 2018 – 2028
          7.6.3. MEA Cell Viability Assays Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.6.4. MEA Cell Viability Assays Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Cell Viability Assays Providers
        8.4.1 Thermo Fisher Scientific
                8.4.1.1 Business Description
                8.4.1.2 Thermo Fisher Scientific Geographic Operations
                8.4.1.3 Thermo Fisher Scientific Financial Information
                8.4.1.4 Thermo Fisher Scientific Product Positions/Portfolio
                8.4.1.5 Thermo Fisher Scientific Key Developments
        8.4.2 Merck KGaA
                8.4.2.1 Business Description
                8.4.2.2 Merck KGaA Geographic Operations
                8.4.2.3 Merck KGaA Financial Information
                8.4.2.4 Merck KGaA Product Positions/Portfolio
                8.4.2.5 Merck KGaA Key Developments
        8.4.3 Bio-Rad Laboratories
                8.4.3.1 Business Description
                8.4.3.2 Bio-Rad Laboratories Geographic Operations
                8.4.3.3 Bio-Rad Laboratories Financial Information
                8.4.3.4 Bio-Rad Laboratories Product Positions/Portfolio
                8.4.3.5 Bio-Rad Laboratories Key Developments
        8.4.4 GE Healthcare
                8.4.4.1 Business Description
                8.4.4.2 GE Healthcare Geographic Operations
                8.4.4.3 GE Healthcare Financial Information
                8.4.4.4 GE Healthcare Product Positions/Portfolio
                8.4.4.5 GE Healthcare Key Developments
        8.4.5 Danaher Corporation
                8.4.5.1 Business Description
                8.4.5.2 Danaher Corporation Geographic Operations
                8.4.5.3 Danaher Corporation Financial Information
                8.4.5.4 Danaher Corporation Product Positions/Portfolio
                8.4.5.5 Danaher Corporation Key Developments
        8.4.6 Becton, Dickinson and Company
                8.4.6.1 Business Description
                8.4.6.2 Becton, Dickinson and Company Geographic Operations
                8.4.6.3 Becton, Dickinson and Company Financial Information
                8.4.6.4 Becton, Dickinson and Company Product Positions/Portfolio
                8.4.6.5 Becton, Dickinson and Company Key Developments
        8.4.7 Promega Corporation
                8.4.7.1 Business Description
                8.4.7.2 Promega Corporation Geographic Operations
                8.4.7.3 Promega Corporation Financial Information
                8.4.7.4 Promega Corporation Product Positions/Portfolio
                8.4.7.5 Promega Corporation Key Developments
        8.4.8 Abcam PLC
                8.4.8.1 Business Description
                8.4.8.2 Abcam PLC Geographic Operations
                8.4.8.3 Abcam PLC Financial Information
                8.4.8.4 Abcam PLC Product Positions/Portfolio
                8.4.8.5 Abcam PLC Key Developments
        8.4.9 Perkinelmer
                8.4.9.1 Business Description
                8.4.9.2 Perkinelmer Geographic Operations
                8.4.9.3 Perkinelmer Financial Information
                8.4.9.4 Perkinelmer Product Positions/Portfolio
                8.4.9.5 Perkinelmer Key Developments
        8.4.10 Biotek Instruments
                8.4.10.1 Business Description
                8.4.10.2 Biotek Instruments Geographic Operations
                8.4.10.3 Biotek Instruments Financial Information
                8.4.10.4 Biotek Instruments Product Positions/Portfolio
                8.4.10.5 Biotek Instruments Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Cell Viability Assays Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Cell Viability Assays Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Cell Viability Assays Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Cell Viability Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Cell Viability Assays Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Cell Viability Assays Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Cell Viability Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Cell Viability Assays Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Cell Viability Assays Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Cell Viability Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Cell Viability Assays Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Cell Viability Assays Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Cell Viability Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Cell Viability Assays Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Cell Viability Assays Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Cell Viability Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Cell Viability Assays: Market Segmentation 
FIG. 2 Global Cell Viability Assays Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Cell Viability Assays Market, By Product, 2019 (US$ Mn) 
FIG. 5 Global Cell Viability Assays Market, By End UserEnd Users, 2019 (US$ Mn) 
FIG. 6 Global Cell Viability Assays Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Cell Viability Assays Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Cell Viability Assays Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Cell Viability Assays Providers, 2019
FIG. 11 Global Cell Viability Assays Market Revenue Contribution, By Product, 2019 & 2028 (Value %) 
FIG. 12 Global Cell Viability Assays Market Revenue Contribution, By End UserEnd Users, 2019 & 2028 (Value %) 
FIG. 13 Global Cell Viability Assays Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Cell Viability Assays Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Cell Viability Assays Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Cell Viability Assays Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Cell Viability Assays Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Cell Viability Assays Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Cell Viability Assays market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Cell Viability Assays Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Cell Viability Assays Market Value, By Segment1, 2018 – 2028
TABLE  North America Cell Viability Assays Market Value, By Segment2, 2018 – 2028
TABLE  North America Cell Viability Assays Market Value, By Country, 2018 – 2028
TABLE  Europe Cell Viability Assays Market Value, By Segment1, 2018 – 2028
TABLE  Europe Cell Viability Assays Market Value, By Segment2, 2018 – 2028
TABLE  Europe Cell Viability Assays Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Cell Viability Assays Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Cell Viability Assays Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Cell Viability Assays Market Value, By Country, 2018 – 2028
TABLE  Latin America Cell Viability Assays Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Cell Viability Assays Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Cell Viability Assays Market Value, By Country, 2018 – 2028
TABLE  MEA Cell Viability Assays Market Value, By Segment1, 2018 – 2028
TABLE  MEA Cell Viability Assays Market Value, By Segment2, 2018 – 2028
TABLE  MEA Cell Viability Assays Market Value, By Country, 2018 – 2028
TABLE  Thermo Fisher Scientific: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck KGaA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bio-Rad Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GE Healthcare: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Danaher Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Becton, Dickinson and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Promega Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abcam PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Perkinelmer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biotek Instruments: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Cell Viability Assays Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Cell Viability Assays Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Cell Viability Assays Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Cell Viability Assays Market, By Geography, 2019 (US$ Mn)
FIG.  Global Cell Viability Assays Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Cell Viability Assays Providers, 2016
FIG.  Global Cell Viability Assays Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Instruments Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cell Viability Assays Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Cell Viability Assays Market Value, 2018 – 2028, (US$ Mn)